[PDF][PDF] Initial drug resistance to anti-tuberculosis drugs in urban and rural district tuberculosis programme

S Chandrasekaran, P Jagota, K Chaudhuri - Indian J Tuberc, 1992 - Citeseer
… Tables 4 and 5 show the pattern of resistance to anti-tuberculosis drugs from Bangalore
and Kolar district respectively. It is seen that single drug resistance to Ethambutol is nil in both …

Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals

S Eminzade, F Uras, FV Izzettin - Nutrition & metabolism, 2008 - Springer
drugs with INH+RIF and INH+RIF+PZA. Hepatoprotective effect of silymarin was investigated
by co-administration of silymarin together with the drugs. … against anti-tuberculosis drugs by …

Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs

BR Imperiale, MJ Zumárraga… - … of tuberculosis and …, 2013 - ingentaconnect.com
… The indirect proportion method on LJ (ILJ) and the MGIT 960® SIRE kit were used to
determine the drug resistance profile of isolates against first-line anti-tuberculosis drugs and …

Tuberculoma of the brain: a series of 16 cases treated with anti-tuberculosis drugs

MNA Idris, TE Sokrab, MAR Arbab… - … of tuberculosis and …, 2007 - ingentaconnect.com
… and response to anti-tuberculosis treatment. Histopathology of … The lesions completely cleared
on anti-tuberculosis treatment … We advocate early empirical trial of anti-tuberculosis drugs

Multicomponent crystals of anti-tuberculosis drugs: a mini-review

E Batisai - RSC advances, 2020 - pubs.rsc.org
drugs reveals that, despite many drug candidates showing initial promise, the emergence
of drug … It quickly became evident that single-drug therapy would most likely result in the …

Recent advances in new structural classes of anti-tuberculosis agents

A Nayyar, R Jain - Current medicinal chemistry, 2005 - ingentaconnect.com
… considered as an important lead molecule for further anti-tuberculosis drug development. …
has been identified as novel target for anti-tuberculosis drug development [26]. Inhibitors of this …

Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis

X Xu, B Dong, L Peng, C Gao, Z He, C Wang… - Frontiers in …, 2022 - frontiersin.org
… targets for anti-TB drug development. In this mini review, we summarized the potential
drugs and drug targets existing in the biosynthetic pathways of mycobacteria cell envelope. …

Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey

D Lukoye, F Adatu, K Musisi, GW Kasule, W Were… - PloS one, 2013 - journals.plos.org
… Data on national anti-TB drug resistance rates and patterns in Uganda do not exist. The
present study is the first national anti-tuberculosis drug resistance survey in Uganda conducted …

[PDF][PDF] Surveillance of drug resistance to anti-tuberculosis drugs in districts of Hoogli in West Bengal and Mayurbhanj in Orissa

B Mahadev, P Kumar, SP Agarwal, LS Chauhan… - Indian J …, 2005 - researchgate.net
… Objective: To measure the levels and pattern of resistance to anti-tuberculosis drugs among
“newly diagnosed” sputum smear positive pulmonary tuberculosis cases in two identified …

In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis

LA Hegeto, KR Caleffi-Ferracioli… - Tuberculosis, 2018 - Elsevier
… of various drugs, the current assay evaluated the combined activity of PIP and anti-TB drugs
in … of anti-TB drugs with PIP determined by resazurin drug combination microtiter assay and …